AnalystsInsight

Nehal Chokshi (Northland Securities): Analyst Track Record and Price‑Target Accuracy

How often Nehal Chokshi’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,028 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Nehal Chokshi ranks #134 of 1,000 analysts in Exent’s scoring (5.0★).
  • 39.2% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 91 days; 63.7% of calls were up 12 months later.
  • Most‑covered stocks: ALLT, NBIS, AGYS, INV.

Nehal Chokshi’s track record at a glance

Nehal Chokshi of Northland Securities ranks #134 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on technology. Over a 7‑year lookback, 39.2% of Nehal’s price targets were reached, 13.2 points below the 52.4% average across all analysts.

MetricNehal ChokshiAll analysts
Price‑target hit rate39.2%52.4%
Median days to hit target91 days91 days
Calls up after 12 months63.7%64.0%
Median 12‑month return of calls+20.2%+13.4%
Hit rate, last 2 years31.0%—
Average worst drop after a call−26.7%—
Ratings in the sample1,028—
Stocks covered37—

How fast price targets were reached

Time to reach the targetNehal Chokshi
Under 30 days25.5%
30–90 days23.9%
90–180 days31.0%
Over 180 days19.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Nehal Chokshi covers most

StockRatings in the sample
ALLT36
NBIS31
AGYS29
INV27
CRWV27
SMCI26
TLS23
FC23

In the past year Nehal’s ratings were 81% Buy, 19% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 18, 2026BRUNInitiated Coverage: BuyBuy$36.00
Sep 18, 2026SHAZInitiated Coverage: BuyBuy$95.00
Sep 18, 2026IRENInitiated Coverage: BuyBuy$99.00
Sep 18, 2026CHRNInitiated Coverage: BuyBuy$32.00
Sep 18, 2026NBISReiterated: BuyBuy$410.00
Sep 10, 2026IONQReiterated: BuyBuy$70.00
Sep 3, 2026NTAPReiterated: BuyBuy$187.00
Sep 2, 2026PANWReiterated: HoldHold$360.00
Sep 1, 2026XNDUReiterated: BuyBuy$43.00
Aug 28, 2026PRated: BuyBuy$128.00
Aug 27, 2026NTNXRated: HoldHold$70.00
Aug 27, 2026CRMReiterated: HoldHold$253.00
  • Sep 18, 2026
    Stock
    BRUN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $36.00
  • Sep 18, 2026
    Stock
    SHAZ
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $95.00
  • Sep 18, 2026
    Stock
    IREN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $99.00
  • Sep 18, 2026
    Stock
    CHRN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $32.00
  • Sep 18, 2026
    Stock
    NBIS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $410.00
  • Sep 10, 2026
    Stock
    IONQ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $70.00
  • Sep 3, 2026
    Stock
    NTAP
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $187.00
  • Sep 2, 2026
    Stock
    PANW
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $360.00
  • Sep 1, 2026
    Stock
    XNDU
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $43.00
  • Aug 28, 2026
    Stock
    P
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $128.00
  • Aug 27, 2026
    Stock
    NTNX
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $70.00
  • Aug 27, 2026
    Stock
    CRM
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $253.00

Live ratings from Nehal Chokshi and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Nehal Chokshi’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Nehal Chokshi ranks #134 of 1,000 with a 5.0★ rating. 39.2% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 63.7% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Nehal Chokshi’s success rate is 59.5% by the ranking source and 39.2% by Exent’s price-target hit-rate backtest, with a median of 91 days to reach a target.

Nehal Chokshi (Northland Securities) covers 37 stocks, mostly in technology. The most frequently rated are ALLT, NBIS, AGYS, INV, CRWV.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.